Having said that, in the managed postmarketing discontinuation study of worry ailment people, the period of therapy (3 months in comparison to six months) experienced no effect on the flexibility of sufferers to taper to zero dose. In distinction, individuals handled with doses of ALPRAZOLAM greater than 4 mg/working day had additional problem tape